Alnylam Pharmaceuticals | ALNY - Eps Gewinn Pro Aktie


Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q3 Sep/2026 16.26 1.97 2.90 Oct/29
FY2026Q2 Jun/2026 1.84 1.61 0.32 Jul/30
FY2026Q1 Mar/2026 1.99 0.99 -0.01 Apr/30
FY2025Q4 Dec/2025 1.25 1.27 0.06 Feb/12
FY2025Q3 Sep/2025 2.90 0.27 -0.50 Oct/30




Eps Veränderung Datum
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agios Pharmaceuticals USD -1.09 0.6 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Amgen USD 6.45 0.16 2026-09
Arrowhead Research USD -5.11 3.75 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Incyte USD -3.6 6.69 2026-09
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
Moderna USD 0.38 2.35 2026-09
Neurocrine Biosciences USD 3.29 0.44 2026-09
Novartis USD 0.63 1.36 2026-09
PTC Therapeutics USD -0.62 1.54 2026-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 0.14 2.02 2026-06
Sarepta Therapeutics USD 0.13 0.51 2026-09
Takeda JPY 116.95 45.3 2026-09
Tectonic Therapeutic USD -1.18 0.17 2026-06
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09
Xencor USD 0.5 0.79 2026-09